Fas ligand mediates activation-induced cell death in human T lymphocytes.

Mark R. Alderson(Research & Development Corporation), Teresa W. Tough(Research & Development Corporation), Terri Davis‐Smith(Research & Development Corporation), S Braddy(Research & Development Corporation), Ben Falk(Research & Development Corporation), Ken Schooley(Research & Development Corporation), Raymond G. Goodwin(Research & Development Corporation), Craig A. Smith(Research & Development Corporation), Fred Ramsdell(Research & Development Corporation), David H. Lynch(Research & Development Corporation)
The Journal of Experimental Medicine
January 1, 1995
Cited by 948Open Access
Full Text

Abstract

A significant proportion of previously activated human T cells undergo apoptosis when triggered through the CD3/T cell receptor complex, a process termed activation-induced cell death (AICD). Ligation of Fas on activated T cells by either Fas antibodies or recombinant human Fas-ligand (Fas-L) also results in cytolysis. We demonstrate that these two pathways of apoptosis are causally related. Stimulation of previously activated T cells resulted in the expression of Fas-L mRNA and lysis of Fas-positive target cells. Fas-L antagonists inhibited AICD of T cell clones and staphylococcus enterotoxin B (SEB)-specific T cell lines. The data indicate AICD in previously stimulated T cells is mediated by Fas/Fas-L interactions.


Related Papers

No related papers found

Powered by citation graph analysis